Does atorvastatin affect androgen levels in men in the era of very-low LDL targeting therapy?

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 2, 2009, Pages 60-63

  Kocum, Tolga H ^a,c   Ozcan, Turkay I ^b   Gen, Ramazan ^b   Tekin, Abdullah ^a   Erol, Tansel ^a   Akcay, Burak ^b   Dover, Oben ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Androgens; Coronary artery disease; Statins

Indexed keywords

ATORVASTATIN; CREATINE KINASE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; CHOLESTEROL, LDL; CORONARY DISEASE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES;

EID: 61849171198     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-2008-1077066     Document Type: Article

References (19)

1. ATP III final report. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421
2. Azhar S, Tsai L, Medicherla S, Chandrasekher Y, Giudice L, Reaven E. Human granulosa cells use high density lipoprotein cholesterol for steroidogenesis. J Clin Endocrinol Metab 1998; 83: 983-991
3. Azzarito C, Boiardi L, Zini M, Agosti A, Dotti C, Biagi R, Portioli I. Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients. Metabolism 1992; 41: 148-153
4. Bernini GP, Argenio GF, Gasperi M, Vivaldi MS, Franchi F, Salvetti A. Effects of long-term simvastatin treatment on testicular and adrenal steroidogenesis in hypercholesterolemic patients. J Endocrinol Invest 1994; 17: 227-233
5. Böhm M, Herrmann W, Wassmann S, Laufs U, Nickenig G. Does statin therapy influence steroid hormone synthesis? Z Kardiol 2004; 93: 43-48
6. Carr BR, Parker Jr CR, Ohashi M, MacDonald PC, Simpson ER. Regulation of human fetal testicular secretion of testosterone: low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am J Obstet Gynecol 1983; 146: 241-247
7. Dobs AS, Miller S, Neri G, Weiss S, Tate AC, Shapiro DR, Musliner TA. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients. Metabolism 2000; 49: 115-121
8. Dobs AS, Sarma PS, Schteingart D. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme-A reductase inhibitor. Metabolism 1993;42:1146-1152
9. Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism 2000; 49: 1234-1238
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
11. Grundy SM, Cleeman JI, Merz ON, Brewer Jr HB, Clark II, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-239
12. Gwynne JI, Strauss III JF. The role of lipoprotein in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982; 3: 299-329
13. Ichihara K, Satoh K. Disparity between angiographic regression and clinical event rates with hydrophobic statins. Lancet 2002;359:2195-2198
14. Jay RH, Sturley RH, Stirling C, MacGarrigle HH, Katz M, Reckless JP, Betteridge DJ. Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolemia. Br J Clin Pharmacol 1991; 32: 417-422
15. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK, Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-1435
16. Purvis K, Tollefsrud A, Rui H, Haug E, Norseth J, Viksmoen L, Ose L, Lund H. Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol 1992; 42: 61-64
17. Santini SA, Carrozza C, Lulli P, Zuppi C, CarloTonolo G, Musumeci S. Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia. J Atheroscler Thromb 2003;10: 160-164
18. Travia D, Tosi F, Negri C, Faccini G, Moghetti P, Muggeo M. Sustained therapy with 3-hydroxy-3-methylglutaryl-Coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads. J Clin Endocrinol Metab 1995;80:836-840
19. Tureck RW, Strauss III JF. Progesterone synthesis by luteinized human granulosa cells in culture: the role of de novo sterol synthesis and lipoprotein-carried sterol. J Clin Endocrinol Metab 1982;54:367-373